Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures.
Chang SH, Ice RJ, Chen M, Sidorov M, Woo RWL, Rodriguez-Brotons A, Jian D, Kim HK, Kim A, Stone DE, Nazarian A, Oh A, Tranah GJ, Nosrati M, de Semir D, Dar AA, Desprez PY, Kashani-Sabet M, Soroceanu L, McAllister SD.
Chang SH, et al. Among authors: desprez py.
Mol Cancer Ther. 2023 Sep 5;22(9):1100-1111. doi: 10.1158/1535-7163.MCT-22-0486.
Mol Cancer Ther. 2023.
PMID: 37440705